Literature DB >> 8542262

Antigen specificity in hydralazine associated ANCA positive systemic vasculitis.

A K Short1, C M Lockwood.   

Abstract

The anti-hypertensive agent hydralazine can cause a lupus-like syndrome characterized by serosal inflammation, arthralgias and rashes. The kidneys however are usually spared. The condition is characterized by circulating immune complexes and antinuclear antibodies, whilst antibodies against double-stranded DNA are rare. Hydralazine can also cause a systemic vasculitis with a pauci-immune rapidly progressive glomerulonephritis, which is associated with autoantibodies directed against components of the neutrophil cytoplasm. In this study, ten patients with hydralazine-induced vasculitis had antibodies with specificities for both myeloperoxidase and lactoferrin. We suggest that this particular pattern of autoantibodies, together with antibodies with reactivity against nuclear components including double-stranded DNA, are characteristic findings in hydralazine-induced vasculitis. In addition, renal involvement appears to be more common in this group of patients with vasculitis than in those with the lupus-like syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542262

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Antineutrophil cytoplasmic antibody-positive vasculitis associated with propylthiouracil therapy.

Authors:  S Dinmezel; C Ogus; T Ozdemir
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

2.  Combined ANCA-associated vasculitis and lupus syndrome following prolonged use of hydralazine: a timely reminder of an old foe.

Authors:  N Sangala; R W Lee; C Horsfield; D J A Goldsmith
Journal:  Int Urol Nephrol       Date:  2009-08-15       Impact factor: 2.370

Review 3.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 4.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Julia Flint; Matthew D Morgan; Caroline O S Savage
Journal:  Rheum Dis Clin North Am       Date:  2010-06-23       Impact factor: 2.670

Review 5.  The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis.

Authors:  Lisa C Willcocks; Paul A Lyons; Andrew J Rees; Kenneth G C Smith
Journal:  Arthritis Res Ther       Date:  2010-02-15       Impact factor: 5.156

6.  Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

7.  ANCA-associated Goodpasture's syndrome in a patient with rheumatoid arthritis on penicillamine.

Authors:  R Sharma; S Jain; V Kher
Journal:  Indian J Nephrol       Date:  2012-01

8.  Hydralazine-induced vasculitis presenting with ocular manifestations.

Authors:  Vivian S Hawn; Thomas A Vo; David Flomenbaum; Richard P Gibralter
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

Review 9.  Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.

Authors:  Karim Doughem; Ayman Battisha; Omar Sheikh; Lakshmi Konduru; Bader Madoukh; Mohammed Al-Sadawi; Shakil Shaikh
Journal:  Curr Cardiol Rev       Date:  2021

10.  Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report.

Authors:  Justin Keasberry; Jeremy Frazier; Nicole M Isbel; Carolyn L Van Eps; Kimberley Oliver; David W Mudge
Journal:  J Med Case Rep       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.